COVID-19: Do not put the cart before the horse

The SARS-CoV-2 pandemic has led to the study of a multitude of drugs to alleviate the epidemic burden. Among them, only corticotherapy (dexamethasone) and more recently concomitant anti-inflammatory therapy with IL-6 antagonists have shown benefit on mortality and mechanic ventilation requirement in patients requiring oxygen support. The management of patients with COVID-19 relies mainly on established therapeutic principles : adequate oxygen therapy, protective mechanic ventilation, prophylactic anticoagulation and targeted antibiotic therapy in case of secondary infection. Other studied drugs, without proven significant benefit to this day, are not recommended in order to avoid complications and costs. Studies are still ongoing for some drugs and new evidence should be closely monitored.